The IMPROVE-IT study, the large cardiovascular-outcomes trial that showed a clinical benefit to adding ezetimibe to statin therapy in post–acute coronary syndrome patients, is now published.
This content is restricted. If you have already registered on the AJP website please login below, Or you can Register for free.
Register here
No Comment